Instruments

Name Stock exchange Average volume Price Type
GE AEROSPACE GE

Nyse +16 Other

5,591,011 161.2 USD Stock GE Aerospace Stock
GE AEROSPACE GNE

Euronext Paris

568 149.5 EUR Stock GE Aerospace
GE AEROSPACE GE

Swiss Exchange

- 147 CHF Stock GE Aerospace
GE AEROSPACE GCP

Deutsche Boerse AG

811 149.5 EUR Stock GE Aerospace
GENERAL ELECTRIC COMPANY GE *

Mexican S.E.

133 2,731 MXN Stock General Electric Company
GE AEROSPACE GCP

Frankfurt

2,867 149.5 EUR Stock GE Aerospace
GENERAL ELECTRIC COMPANY GE

Wiener Boerse

- 149.5 EUR Stock General Electric Company
GE AEROSPACE GCP

Börse Stuttgart

486 150 EUR Stock GE Aerospace
GENERAL ELECTRIC COMPANY GE

Bolsa De Valores De Colombia

- 6,20,160 COP Stock General Electric Company
GENERAL ELECTRIC COMPANY GE

Santiago S.E.

- 116.4 USD Stock General Electric Company
GE AEROSPACE GCP

BOERSE MUENCHEN

613 148.5 EUR Stock GE Aerospace
GENERAL ELECTRIC COMPANY GE

Lima

- 151.5 USD Stock General Electric Company
GENERAL ELECTRIC COMPANY GEC

London S.E.

9,269 105 USD Stock General Electric Company
GENERAL ELECTRIC COMPANY 4GE

Borsa Italiana

34 147.5 EUR Stock General Electric Company
GENERAL ELECTRIC COMPANY GCP

Bulgaria S.E.

3 137.5 EUR Stock General Electric Company
GE AEROSPACE GE

Berne S.E.

28 142.3 CHF Stock GE Aerospace
GENERAL ELECTRIC COMPANY GECL

Santiago S.E.

- 1,70,666 CLP Stock General Electric Company
GE AEROSPACE GEOO34

Sao Paulo

1,152 830.5 BRL Stock GE Aerospace Stock
GE VERNOVA INC. GEV

Nyse +6 Other

3,647,990 166.4 USD Stock GE Vernova Inc. Stock
GE VERNOVA INC. GEV *

Mexican S.E.

1,585 2,824 MXN Stock GE Vernova Inc.
GE VERNOVA LLC Y5C

Deutsche Boerse AG

729 157 PTS Stock GE Vernova LLC
GE VERNOVA INC. Y5C

Deutsche Boerse AG

710 157 EUR Stock GE Vernova Inc.
GE VERNOVA INC. Y5C

Börse Stuttgart

138 156 EUR Stock GE Vernova Inc.
GE VERNOVA INC. Y5C

BOERSE MUENCHEN

419 153 EUR Stock GE Vernova Inc.
GE VERNOVA INC. Y5C

Bulgaria S.E.

- 156.5 EUR Stock GE Vernova Inc.
GE HEALTHCARE TECHNOLOGIES INC. GEHC

Nasdaq +5 Other

3,446,266 81.26 USD Stock GE HealthCare Technologies Inc. Stock
GE HEALTHCARE TECHNOLOGIES INC. L0T

Börse Stuttgart

54 75.21 EUR Stock GE HealthCare Technologies Inc.
GE HEALTHCARE TECHNOLOGIES INC. GEHC *

Mexican S.E.

665 1,361 MXN Stock GE HealthCare Technologies Inc.
GE HEALTHCARE TECHNOLOGIES INC. L0T

Deutsche Boerse AG

245 74.88 EUR Stock GE HealthCare Technologies Inc.
GE HEALTHCARE TECHNOLOGIES INC. L0T

BOERSE MUENCHEN

330 75.24 EUR Stock GE HealthCare Technologies Inc.
GE HEALTHCARE TECHNOLOGIES INC. L0T

Berne S.E.

- - CHF Stock GE HealthCare Technologies Inc.
ME LIN STEEL MEL

HANOI S.E.

556 6,700 VND Stock Me Lin Steel Stock
LIN BIOSCIENCE, INC. 6696

Taipei Exchange

370,645 90.4 TWD Stock Lin BioScience, Inc. Stock
GE-SHEN CORPORATION GESHEN

BURSA MALAYSIA

150,453 4.12 MYR Stock GE-Shen Corporation Stock
GE T&D INDIA LIMITED GET&D

Bombay S.E. +1 Other

5,782 1,246 INR Stock GE T&D India Limited Stock
GE T&D INDIA LIMITED GET&D

NSE India S.E.

103,989 1,250 INR Stock GE T&D India Limited
GE POWER INDIA LIMITED GEPIL

Bombay S.E. +1 Other

24,637 335.8 INR Stock GE Power India Limited Stock
GE POWER INDIA LIMITED GEPIL

NSE India S.E.

225,628 335.2 INR Stock GE Power India Limited
TIAN GE INTERACTIVE HOLDINGS LIMITED 1980

Hong Kong S.E. +2 Other

773,954 0.49 HKD Stock Tian Ge Interactive Holdings Limited Stock
TIAN GE INTERACTIVE HOLDINGS LIMITED 04T

Deutsche Boerse AG

- 0.0475 EUR Stock Tian Ge Interactive Holdings Limited
TIAN GE INTERACTIVE HOLDINGS LIMITED TGRVF

OTC Markets

0 0.11 USD Stock Tian Ge Interactive Holdings Limited

News (928)

Fanhua : 2023 Q4 Earnings Call Transcript PU
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy BU
Plus Therapeutics : The use of CNSide in Clinical Management of LMD PU
Johnson & Johnson : receives positive CHMP opinion for RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations PU
Viracta Therapeutics : HST 2024 – Presentation PU
Transcript : Bank of China Limited, 2023 Earnings Call, Apr 02, 2024
Western New England Bancorp : Proxy Statement PU
FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six BU
Transcript : Fanhua Inc., Q4 2023 Earnings Call, Mar 20, 2024
ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease GL
ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease AQ
First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation BU
FANHUA to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results and Host Conference Call on March 20, 2024 AQ
Knight Therapeutics Announces Launch of Bijuva® in Canada GL
Certain A Shares of ChengDa Pharmaceuticals Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-JAN-2024. CI
IMFINZI® (durvalumab) plus transarterial chemoembolization (TACE) and bevacizumab reduced the risk of disease progression or death by 23% vs. TACE in liver cancer eligible for embolization BU
Ironwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional Constipation BU
TELES Informationstechnologien : Annual Financial Statements 2022 PU
Daiichi Sankyo : Two Phase 3 Trials of Datopotamab Deruxtecan Plus Durvalumab Initiated in Patients Across Two Breast Cancer Subtypes(241.9KB PU
Two Phase 3 Trials of Datopotamab Deruxtecan Plus Durvalumab Initiated in Patients Across Two Breast Cancer Subtypes BU
FDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer BU
CIFI Holdings Co. Ltd. Announces Director Changes CI
Certain A Shares of Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 30-NOV-2023. CI
TRUQAP™ (capivasertib) plus fulvestrant approved in the US for patients with advanced HR-positive breast cancer BU
U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) BU
IMFINZI® (durvalumab) plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolization in EMERALD-1 Phase III trial BU
FANHUA Provides Select Preliminary Financial Results and Schedules to Report Third Quarter 2023 Financial Results on November 20, 2023 AQ
Johnson & Johnson : New Data from Phase 3 PAPILLON Study Show RYBREVANT® (amivantamab-vmjw) Plus Chemotherapy Resulted in 60% Reduction in Risk of Disease Progression or Death in Patients with Previously Untreated EGFR Exon 20 Insertion Mutation-Positive NSCLC PU
Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting BU
Datopotamab deruxtecan plus IMFINZI® (durvalumab) demonstrated robust and durable tumor responses in 1st-line treatment of patients with metastatic triple-negative breast cancer in BEGONIA Phase Ib/II trial BU
Johnson & Johnson : New Data from Phase 3 PAPILLON Study Show RYBREVANT® (amivantamab-vmjw) Plus Chemotherapy Resulted in 60% Reduction in Risk of Disease Progression or Death in Patients with Previously Untreated EGFR Exon 20 Insertion Mutation-Positive NSCLC PU
FantasTech Sale II, Newegg’s Big Fall Extravaganza, Offers Incredible Deals on Must-Have Tech Products BU
Johnson & Johnson : Landmark Phase 3 MARIPOSA Study Meets Primary Endpoint Resulting in Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival for RYBREVANT® (amivantamab-vmjw) plus Lazertinib Versus Osimertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer PU
Certain A Shares of Zhe Jiang Headman Machinery Co.,Ltd. are subject to a Lock-Up Agreement Ending on 16-SEP-2023. CI
Transcript : Fanhua Inc., Q2 2023 Earnings Call, Aug 30, 2023
Fanhua to Announce Second Quarter 2023 Unaudited Financial Results and Host Conference Call on August 30, 2023 AQ
Andes Technology and TetraMem Collaborate to Build Groundbreaking AI Accelerator Chip with Analog In-Memory Computing AQ
TaChan Securities Co.,Ltd. Announces Changes in the Risk Management Committee Members CI
Focus Hotmelt Company Ltd. Announces Executive Appointments CI
AcBel Polytech Inc. acquired GE Power Electronics, Inc. from ABB Ltd for $505 million. CI
LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in Singapore AQ
Jinli Group Holdings Limited Announces Directorate Changes CI
Capivasertib in combination with FASLODEX® (fulvestrant) granted Priority Review in the US for patients with advanced HR-positive breast cancer BU
Ciltacabtagene Autoleucel (cilta-cel) Reduced Risk of Disease Progression or Death by 74% vs Standard Regimens for Adult Patients with Relapsed and Refractory Multiple Myeloma in CARTITUDE-4 Study BU
English translation : Board of Directors Report to the Combined General Shareholders Meeting to be held on June 27, 2023 on Stock Options and Restricted Free Shares PU
1234NextSee all

Companies (42)

GE VERNOVA INC. 45 608 M $
Logo GE Vernova Inc.

Resulting from the spin-off of the GE Aerospace group's power generation equipment design and manufacturing activity, GE Vernova Inc. is an industrial group organized around 3 areas of activity: - manufacture and maintenance of gas, nuclear, hydroelectr ...

GE HEALTHCARE TECHNOLOGIES INC. 37 115 M $
Logo GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatm ...

GLOBAL ARENA HOLDING INC. 517 957 $
Logo Global Arena Holding Inc.

Global Arena Holding, Inc. is a holding company, which operates through its subsidiaries, including Global Election Services (GES), Tidewater Energy Group Inc. and GAHI Acquisition Corp. GES provides technology-enabled paper absentee/mail ballot and onlin ...

VIAD CORP 750 M $
Logo Viad Corp

Viad Corp is engaged in hospitality and leisure activities, experiential marketing and live events. Its segments include Pursuit, Spiro, and GES Exhibitions. The Pursuit segment is a collection of travel experiences that includes hotels and lodges, food a ...

GE-SHEN CORPORATION 110 M $
Logo GE-Shen Corporation

Ge-Shen Corporation Berhad is engaged in the business of investment holding and the provision of management services. The Company is organized into two main geographical segments: Malaysia and Singapore, and Vietnam. Malaysia and Singapore segment manufac ...

HANNONG CHEMICALS INC. 197 M $
Logo Hannong Chemicals Inc.

HANNONG CHEMICALS INC is a Korea-based company principally engaged in the manufacture and sale of ethylene oxide additives (EOAs). The Company operates its business through three segments. The EOA segment manufactures surfactants used in softeners, antist ...

CHEN LIN EDUCATION GROUP HOLDINGS LIMITED 191 M $
Logo Chen Lin Education Group Holdings Limited

Chen Lin Education Group Holdings Limited is a China-based company principally engaged in the provision of private higher education services. The Company’s education-related services mainly include internship management services and training services, a ...

JIH LIN TECHNOLOGY CO., LTD. 210 M $
Logo Jih Lin Technology Co., Ltd.

Jih Lin Technology Co., Ltd. is a Taiwan-based company principally engaged in the research, development, manufacture and sales of various kinds of power lead frames. The Company's main products include power unit lead frames, optoelectronic component lead ...

ME LIN STEEL 4 M $
Logo Me Lin Steel

Me Lin Steel Joint Stock Company is a Vietnam-based company primarily engaged in the steel industry. The Company's leading business activity is the trading of steel, including hot rolled steel coils, cold rolled steel coils, rolled galvanized steel coils, ...

ENGRO POWERGEN QADIRPUR LIMITED 33 M $
Logo Engro Powergen Qadirpur Limited

Engro Powergen Qadirpur Limited is a Pakistan-based company engaged in the business of generation and sale of power. The Company has approximately 217 megawatts (MW) combined cycle power plant and the green facility in Pakistan to utilize permeate gas for ...


1234Next

Insiders


Picture Lin Geng
Lin Geng

Lin Geng is associated with Xi'an Qujiang Cultural Tourism Co., Ltd.
as Chairman since 2021 and Xi'an Modern Chinatown Management Co., Ltd.
as General Manager & Executive Director.




Picture Lin Geng
Lin Geng

Lin Geng is an Independent Director at Solbar Ningbo Protein Technology Co., Ltd.
since 2021.
Previously, she held the same position at Henan Mingtai Al.
Industrial Co., Ltd.


Picture Lin Gen Wang
Lin Gen Wang

Lin Gen Wang is currently the General Manager & Director at Chongqing Brewery Ningbo Daliangshan Co., Ltd.





No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW